Etoricoxib (C007B-144976)

EtoricoxibEtoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood). A specific inhibitor of COX-2. Specification: ≥98.0% MDL Number: MFCD06797512 Molecular Formula: C18H15ClN2O2S Molecular Weight: 358.84 PubChem CID: 123619 Isomeric SMILES: CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C Beilstein Registry Number: 8073797 Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/E126660-SCI_96f905ae888e1462ea6a272196797c43.pdf

UPC:

51112802

Condition:

New

Weight:

0.96 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

E126660-10mg

CAS:

202409-33-4

Product Size:

10mg